AGXT and primary hyperoxaluria type 1: The diagnosis of PH1 is established in a proband with hyperoxaluria or hyperoxalemia by genetic testing identifying biallelic pathogenic genetic variants of AGXT. The spectrum of PH1-associated genetic variants is highly heterogeneous, with more than 350 genetic variants currently listed in the ClinVar database (13).